Covid-19 pins geographic needles in Ambu's core business – CEO hopes for stabilization ahead
Compared to last year, sales growth for single-use endoscopes seems to have reached a standstill at Ambu.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu joins green climate initiative
For subscribers
Ambu's Q3 ended better than expected
For subscribers